Abstract

We examined the effects of a communication intervention to engage family care partners on patient portal (MyChart) use, illness understanding, satisfaction with cancer care, and symptoms of anxiety in a single-blind randomized trial of patients in treatment for breast cancer. Patient-family dyads were recruited and randomly assigned a self-administered checklist to clarify the care partner role, establish a shared visit agenda, and facilitate MyChart access (n = 63) or usual care (n = 55). Interviews administered at baseline, 3, 9 (primary endpoint), and 12 months assessed anxiety (GAD-2), mean FAMCARE satisfaction, and complete illness understanding (4 of 4 items correct). Time-stamped electronic interactions measured MyChart use. By 9 months, more intervention than control care partners registered for MyChart (77.8 % vs 1.8%; p < 0.001) and logged into the patient’s account (61.2% vs 0% of those registered; p < 0.001), but few sent messages to clinicians (6.1% vs 0%; p = 0.247). More intervention than control patients viewed clinical notes (60.3% vs 32.7%; p = 0.003). No pre-post group differences in patient or care partner symptoms of anxiety, satisfaction, or complete illness understanding were found. Intervention patients whose care partners logged into MyChart were more likely to have complete illness understanding at 9 months (changed 70.0% to 80.0% vs 69.7% to 54.6%; p = 0.03); symptoms of anxiety were numerically lower (16.7% to 6.7% vs 15.2% to 15.2%; p = 0.24) and satisfaction numerically higher (15.8–16.2 vs 18.0–17.4; p = 0.25). A brief, scalable communication intervention led to greater care partner MyChart use and increased illness understanding among patients with more engaged care partners (NCT03283553).

Details

Title
A randomized intervention involving family to improve communication in breast cancer care
Author
Wolff, Jennifer L 1 ; Aufill, Jennifer 1 ; Echavarria, Diane 1 ; Blackford, Amanda L 2 ; Connolly, Roisin M 2 ; Fetting, John H 2 ; Jelovac Danijela 2 ; Papathakis Katie 3 ; Riley, Carol 3 ; Stearns Vered 2 ; Zafman Nelli 3 ; Thorner Elissa 3 ; Levy, Howard P 3   VIAFID ORCID Logo  ; Guo, Amy 1 ; Dy, Sydney M 4 ; Wolff, Antonio C 2   VIAFID ORCID Logo 

 Johns Hopkins Bloomberg School of Public Health, Roger C. Lipitz Center for Integrated Health Care, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311) 
 The Johns Hopkins University School of Medicine, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA (GRID:grid.280502.d) (ISNI:0000 0000 8741 3625) 
 The Johns Hopkins University School of Medicine, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311) 
 Johns Hopkins Bloomberg School of Public Health, Roger C. Lipitz Center for Integrated Health Care, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311); The Johns Hopkins University School of Medicine, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311); The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA (GRID:grid.280502.d) (ISNI:0000 0000 8741 3625) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
23744677
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2488772625
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.